arBtrage CAPITALIZING MARKETS checking… Sign in

Fortress Biotech, Inc.

FBIO Health Care Biotechnology: Pharmaceutical Preparations
$2.65
▼ -4.3% Today
as of Jun 7, 07:14 ET
Last 30 days +18.30% Apr 28 → Jun 05
$2.17 $2.34 $2.51 $2.69 $2.86 Apr 28 May 05 May 13 May 20 May 29 Jun 05
Open
$2.77
High
$2.83
Low
$2.64
Volume
$326,526
Avg Vol
$683,124
Mkt Cap
$93M
P/E (TTM)
0.78
Beta
52w High
$4.53
52w Low
$1.70
Div Yield
Shares Out
$33M

Overview

52-week range
$1.70
$4.53
34% of range
Avg surprise (last 1)
-9.1%
Avg reaction (last 2)
+5.2%
100% positive
Latest IV / EM
109%
EM ±15.1% · $3 · Jun 18

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.65$-2.03$-0.42$1.20$2.82 Actual $-3.65Actual $-0.94Actual $-1.04Actual $-0.73Actual $-0.76Actual $-0.48Est $-0.44Actual $0.45Actual $0.11Actual $2.82 JunSepMarJunSepMar/2025JunSepMar/2026
Revenue vs Net Income Revenue Net income
$-13M$19M$52M$84M$116M Jun 24Sep 24Mar 25Jun 25Sep 25Mar 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Thu May 14, 2026Mar/2026 $2.82 +687.5% +3.1% earnings
Tue Sep 30, 2025Sep 2025 $0.11 financials
Mon Jun 30, 2025Jun 2025 $0.45 financials
Thu May 15, 2025Mar/2025 $-0.48 $-0.44 -9.1% +7.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.76 financials
Sun Jun 30, 2024Jun 2024 $-0.73 financials
Sun Mar 31, 2024Mar 2024 $-1.04 financials
Sat Sep 30, 2023Sep 2023 $-0.94 financials
Fri Jun 30, 2023Jun 2023 $-3.65 financials

Financials

Income statement (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Revenue$16M$18M$16M$13M$15M$15M
Cost of revenue$6M$6M$5M$5M$4M$6M
Gross profit
Operating income$-8M$-7M$-36M$-22M$-22M$-28M
Net income$110M$6M$15M$-11M$-13M$-11M
EPS (diluted)$2.82$0.11$0.45$-0.48$-0.76$-0.73

Balance sheet (quarterly)

MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024
Cash & equivalents$256M$79M$86M$74M$91M$57M$59M$76M
Inventory$9M$10M$12M$13M$12M$14M$12M$10M
Total current assets$295M$124M$119M$110M$127M$90M$86M$103M
Total assets$357M$186M$181M$160M$178M$144M$127M$146M
Long-term debt
Total liabilities$154M$123M$116M$123M$146M$146M$140M$160M
Total equity$162M$50M$56M$44M$22M$23M$21M$18M

Implied volatility — last 90 days

103%106%108%111%113% Jun 07 — IV 109% · EM ±15.1%

Sector peers